Inflammatory response in the acute phase of deep vein thrombosis

Journal of Vascular Surgery

Volumn 35, Issue 4, 2002, Pages 701-706

  Roumen Klappe, Edith M ^a,b   Den Heijer, Martin ^a,b   Van Uum, Stan H M ^a,b   Van Der Ven Jongekrijg, Johanna ^a,b   Van Der Graaf, Fedde D ^a,c   Wollersheim, Hub ^a,b  

^a University Medical Center Nijmegen ^*

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Sint Joseph Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEPARIN; INTERLEUKIN 6; INTERLEUKIN 8; WARFARIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; ACUTE PHASE RESPONSE; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; VEIN THROMBOSIS;

ACUTE-PHASE REACTION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PHLEBOGRAPHY; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0036551021     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.121746     Document Type: Article

References (19)

1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-73.
2. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998;80:874-7.
3. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-5.
4. van Hylckama V, van der Linden I, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000;95:3678-82.
5. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000;342:696-701.
6. van Tilburg MH, Rosendaal FR, Bertina RM. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 2000;95:2855-9.
7. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
8. van Aken BE, den Heijer M, Bos GM, van Deventer SJ, Reitsma PH. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost 2000;83:536-9.
9. van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in the development of thrombosis. Brit J Haem 2002;116:1-5.
10. Kamphuisen PW, Eikenboom JC, Vos HL, et al. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost 1999;81:680-3.
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
12. van der Graaf F, van den Borne H, van der Kolk M, de Wild P, Janssen G, Van Uum S. Exclusion of deep venous thrombosis with D-dimer testing-comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost 2000;83:191-8.
13. Syrjala H, Haukipuro K, Kiviniemi H. Acute phase response and deep lower limb venous thrombosis. J Clin Pathol 1990;43:519-20.
14. Wong NA, Laitt RD, Goddard PR, Virjee J. Serum C reactive protein does not reliably exclude lower limb deep venous thrombosis. Thromb Haemost 1996;76:816-7.
15. Wakefield TW, Greenfield LJ, Rolfe MW, et al. Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost 1993;69:164-72.
16. Froehlich JB, Prince MR, Greenfield LJ, Downing LJ, Shah NL, Wakefield TW. "Bull's-eye" sign on gadolinium-enhanced magnetic resonance venography determines thrombus presence and age: a preliminary study. J Vasc Surg 1997;6:809-16.
17. Wakefield TW, Strieter RM, Schaub R, et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. J Vasc Surg 2000;31:309-24.
18. Downing LJ, Stricter RM, Kadell AM, Wilke CA, Greenfield LJ, Wakefield TW. Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg 1998;28:848-54.
19. Meissner MH, Zierler BK, Bergelin RO, Chandler WC, Manzo RA, Strandness DE. Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis. J Vasc Surg 2000;32:870-80.